Clinical Trial Update: Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating the efficacy and safety of HRS-7249 and SHR-1918 in adults with severe hypertriglyceridemia at high risk of acute pancre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Pancreatitis

Drugs mentioned

• HRS-7249
• SHR-1918

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis | Phase 2 | Status: RECRUITING